Golden State Wealth Management LLC Takes $26,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,735 shares of the pharmacy operator’s stock, valued at approximately $26,000.

Several other large investors have also modified their holdings of WBA. Charles Schwab Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares during the period. Altrius Capital Management Inc lifted its holdings in Walgreens Boots Alliance by 76.6% in the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after acquiring an additional 190,996 shares during the period. Swedbank AB lifted its holdings in Walgreens Boots Alliance by 45.3% in the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock valued at $5,559,000 after acquiring an additional 185,762 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock valued at $3,050,000 after acquiring an additional 64,586 shares during the period. Finally, Sasco Capital Inc. CT lifted its holdings in Walgreens Boots Alliance by 13.6% in the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after acquiring an additional 124,950 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Up 1.2 %

Walgreens Boots Alliance stock opened at $9.47 on Thursday. The stock has a market cap of $8.18 billion, a PE ratio of -0.92, a P/E/G ratio of 1.26 and a beta of 0.65. The stock has a 50-day moving average price of $10.25 and a 200 day moving average price of $9.77. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.55. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the business posted $0.66 EPS. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of recent analyst reports. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Jefferies Financial Group dropped their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Royal Bank of Canada raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Finally, UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $13.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.